SPX3,845.08+13.69 0.36%
DIA310.41+0.70 0.23%
IXIC11,361.85+39.61 0.35%

BRIEF-LumiraDx Achieves CE Mark For Covid-19 Antigen Test On Amira, Its New Low-Cost Testing System

reuters.com · 06/09/2022 09:50
BRIEF-LumiraDx Achieves CE Mark For Covid-19 Antigen Test On Amira, Its New Low-Cost Testing System

- LumiraDx Ltd LMDX:

  • LUMIRADX ACHIEVES CE MARK FOR COVID-19 ANTIGEN TEST ON AMIRA, ITS NEW LOW-COST TESTING SYSTEM

Source text for Eikon: ID:nPn9W66mYa

Further company coverage: LMDX


((Reuters.Briefs@thomsonreuters.com;))